Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 13/20 | 0.51 |
| ▸ | TACR2 | P21452 | 7/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.46 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.41 |
| ▸ | KCNK3 | O14649 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TACR1 | P25103 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1718782 | 0.99 | TACR3 (0.50) | TACR3TACR2OPRM1TRPV4KCNK3 | |
| SCHEMBL1718011 | 0.93 | ALDH1A1 (0.47) | TACR3TACR2OPRM1KCNK3 | |
| SCHEMBL1718897 | 0.92 | TACR3 (0.51) | TACR3TACR2OPRM1TRPV4KCNK3 | |
| SCHEMBL1719007 | 0.91 | TACR3 (0.43) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL1717394 | 0.90 | TACR3 (0.54) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1719079 | 0.89 | TACR3 (0.56) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL1718258 | 0.89 | TACR3 (0.53) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1717579 | 0.89 | TACR2 (0.59) | TACR3TACR2OPRM1TRPV4 | |
| SCHEMBL1717866 | 0.88 | TACR3 (0.49) | TACR3TACR2OPRM1KCNK3 | |
| SCHEMBL1717248 | 0.87 | TACR3 (0.49) | TACR3TACR2OPRM1TRPV4KCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2150534-B1 | ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS | LUNDBECK & CO AS H (DK) | 2012-01-11 | — | — | EP | claimed |
| EP-2150534-B1 | ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS | LUNDBECK & CO AS H (DK) | 2012-01-11 | — | — | EP | disclosed |